[IKT] YoY Quarter Result on 31-Dec-2021 [#Q4]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
31-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -12.77%
YoY- -317.38%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 0 123 2 698 240 -
PBT -4,178 -4,279 -5,042 -1,208 -430 76.48%
Tax 0 -112 -0 -2,841 -422 -
NP -4,178 -4,167 -5,042 -1,208 -430 76.48%
Tax Rate - - - - - -
Total Cost 4,178 4,291 5,044 1,906 670 57.97%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -417,794,000.00 -3,375.91 -259,342.54 -172.95 -178.97 3799.02%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -0.68 -0.99 -1.20 -0.87 -0.32 20.72%
EPS Diluted -0.68 -0.99 -1.20 -0.87 -0.32 20.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.